Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

The role of intraspecies variation in fish neurobehavioral and neuropharmacological phenotypes in aquatic models.

Demin KA, Lakstygal AM, Alekseeva PA, Sysoev M, de Abreu MS, Alpyshov ET, Serikuly N, Wang D, Wang M, Tang Z, Yan D, Strekalova TV, Volgin AD, Amstislavskaya TG, Wang J, Song C, Kalueff AV.

Aquat Toxicol. 2019 May;210:44-55. doi: 10.1016/j.aquatox.2019.02.015. Epub 2019 Feb 20. Review.

PMID:
30822702
2.

Animal models of major depressive disorder and the implications for drug discovery and development.

Demin KA, Sysoev M, Chernysh MV, Savva AK, Koshiba M, Wappler-Guzzetta EA, Song C, De Abreu MS, Leonard B, Parker MO, Harvey BH, Tian L, Vasar E, Strekalova T, Amstislavskaya TG, Volgin AD, Alpyshov ET, Wang D, Kalueff AV.

Expert Opin Drug Discov. 2019 Apr;14(4):365-378. doi: 10.1080/17460441.2019.1575360. Epub 2019 Feb 22.

PMID:
30793996
3.

Opioid Neurobiology, Neurogenetics and Neuropharmacology in Zebrafish.

Bao W, Volgin AD, Alpyshov ET, Friend AJ, Strekalova TV, de Abreu MS, Collins C, Amstislavskaya TG, Demin KA, Kalueff AV.

Neuroscience. 2019 Apr 15;404:218-232. doi: 10.1016/j.neuroscience.2019.01.045. Epub 2019 Jan 31. Review.

PMID:
30710667
4.

DARK Classics in Chemical Neuroscience: Arecoline.

Volgin AD, Bashirzade A, Amstislavskaya TG, Yakovlev OA, Demin KA, Ho YJ, Wang D, Shevyrin VA, Yan D, Tang Z, Wang J, Wang M, Alpyshov ET, Serikuly N, Wappler-Guzzetta EA, Lakstygal AM, Kalueff AV.

ACS Chem Neurosci. 2019 May 15;10(5):2176-2185. doi: 10.1021/acschemneuro.8b00711. Epub 2019 Feb 21.

PMID:
30664352
5.

The evolutionarily conserved role of melatonin in CNS disorders and behavioral regulation: Translational lessons from zebrafish.

Genario R, Giacomini ACVV, Demin KA, Dos Santos BE, Marchiori NI, Volgin AD, Bashirzade A, Amstislavskaya TG, de Abreu MS, Kalueff AV.

Neurosci Biobehav Rev. 2019 Apr;99:117-127. doi: 10.1016/j.neubiorev.2018.12.025. Epub 2019 Jan 3. Review.

PMID:
30611799
6.

DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens.

Lakstygal AM, Kolesnikova TO, Khatsko SL, Zabegalov KN, Volgin AD, Demin KA, Shevyrin VA, Wappler-Guzzetta EA, Kalueff AV.

ACS Chem Neurosci. 2019 May 15;10(5):2144-2159. doi: 10.1021/acschemneuro.8b00615. Epub 2019 Jan 10.

PMID:
30566832
7.

Zebrafish models of diabetes-related CNS pathogenesis.

Lakstygal AM, de Abreu MS, Lifanov DA, Wappler-Guzzetta EA, Serikuly N, Alpsyshov ET, Wang D, Wang M, Tang Z, Yan D, Demin KA, Volgin AD, Amstislavskaya TG, Wang J, Song C, Alekseeva P, Kalueff AV.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:48-58. doi: 10.1016/j.pnpbp.2018.11.016. Epub 2018 Nov 23. Review.

PMID:
30476525
8.

Understanding zebrafish aggressive behavior.

Zabegalov KN, Kolesnikova TO, Khatsko SL, Volgin AD, Yakovlev OA, Amstislavskaya TG, Friend AJ, Bao W, Alekseeva PA, Lakstygal AM, Meshalkina DA, Demin KA, de Abreu MS, Rosemberg DB, Kalueff AV.

Behav Processes. 2019 Jan;158:200-210. doi: 10.1016/j.beproc.2018.11.010. Epub 2018 Nov 20. Review.

PMID:
30468887
9.

Acute behavioral effects of deliriant hallucinogens atropine and scopolamine in adult zebrafish.

Volgin AD, Yakovlev OA, Demin KA, Alekseeva PA, Kalueff AV.

Behav Brain Res. 2019 Feb 1;359:274-280. doi: 10.1016/j.bbr.2018.10.033. Epub 2018 Oct 23.

PMID:
30366034
10.

Zebrafish models for personalized psychiatry: Insights from individual, strain and sex differences, and modeling gene x environment interactions.

Volgin AD, Yakovlev OA, Demin KA, de Abreu MS, Alekseeva PA, Friend AJ, Lakstygal AM, Amstislavskaya TG, Bao W, Song C, Kalueff AV.

J Neurosci Res. 2019 Apr;97(4):402-413. doi: 10.1002/jnr.24337. Epub 2018 Oct 15. Review.

PMID:
30320468
11.

Understanding Central Nervous System Effects of Deliriant Hallucinogenic Drugs through Experimental Animal Models.

Volgin AD, Yakovlev OA, Demin KA, Alekseeva PA, Kyzar EJ, Collins C, Nichols DE, Kalueff AV.

ACS Chem Neurosci. 2019 Jan 16;10(1):143-154. doi: 10.1021/acschemneuro.8b00433. Epub 2018 Oct 16.

PMID:
30252437
12.

Understanding the Role of Environmental Enrichment in Zebrafish Neurobehavioral Models.

Volgin AD, Yakovlev OV, Demin KA, Abreu MS, Rosemberg DB, Meshalkina DA, Alekseeva PA, Friend AJ, Amstislavskaya TG, Kalueff AV.

Zebrafish. 2018 Oct;15(5):425-432. doi: 10.1089/zeb.2018.1592. Epub 2018 Aug 22.

PMID:
30133416
13.

Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models.

Zabegalov KN, Kolesnikova TO, Khatsko SL, Volgin AD, Yakovlev OA, Amstislavskaya TG, Alekseeva PA, Meshalkina DA, Friend AJ, Bao W, Demin KA, Gainetdinov RR, Kalueff AV.

Eur J Pharmacol. 2018 Jun 15;829:129-140. doi: 10.1016/j.ejphar.2018.04.003. Epub 2018 Apr 5. Review.

PMID:
29627310
14.

Zebrafish models relevant to studying central opioid and endocannabinoid systems.

Demin KA, Meshalkina DA, Kysil EV, Antonova KA, Volgin AD, Yakovlev OA, Alekseeva PA, Firuleva MM, Lakstygal AM, de Abreu MS, Barcellos LJG, Bao W, Friend AJ, Amstislavskaya TG, Rosemberg DB, Musienko PE, Song C, Kalueff AV.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:301-312. doi: 10.1016/j.pnpbp.2018.03.024. Epub 2018 Mar 28. Review.

PMID:
29604314
15.

Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models.

Benito J, Ramirez MS, Millward NZ, Velez J, Harutyunyan KG, Lu H, Shi YX, Matre P, Jacamo R, Ma H, Konoplev S, McQueen T, Volgin A, Protopopova M, Mu H, Lee J, Bhattacharya PK, Marszalek JR, Davis RE, Bankson JA, Cortes JE, Hart CP, Andreeff M, Konopleva M.

Clin Cancer Res. 2016 Apr 1;22(7):1687-98. doi: 10.1158/1078-0432.CCR-14-3378. Epub 2015 Nov 24.

16.

Imatinib analogs as potential agents for PET imaging of Bcr-Abl and c-KIT expression at a kinase level.

Peng Z, Maxwell DS, Sun D, Bhanu Prasad BA, Pal A, Wang S, Balatoni J, Ghosh P, Lim ST, Volgin A, Shavrin A, Alauddin MM, Gelovani JG, Bornmann WG.

Bioorg Med Chem. 2014 Jan 1;22(1):623-32. doi: 10.1016/j.bmc.2013.10.040. Epub 2013 Nov 6.

17.

Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor.

Turkman N, Shavrin A, Paolillo V, Yeh HH, Flores L, Soghomonian S, Rabinovich B, Volgin A, Gelovani J, Alauddin M.

Nucl Med Biol. 2012 May;39(4):593-600. doi: 10.1016/j.nucmedbio.2011.10.019. Epub 2012 Jan 4.

18.

Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model.

Perin EC, Tian M, Marini FC 3rd, Silva GV, Zheng Y, Baimbridge F, Quan X, Fernandes MR, Gahremanpour A, Young D, Paolillo V, Mukhopadhyay U, Borne AT, Uthamanthil R, Brammer D, Jackson J, Decker WK, Najjar AM, Thomas MW, Volgin A, Rabinovich B, Soghomonyan S, Jeong HJ, Rios JM, Steiner D, Robinson S, Mawlawi O, Pan T, Stafford J, Kundra V, Li C, Alauddin MM, Willerson JT, Shpall E, Gelovani JG.

PLoS One. 2011;6(9):e22949. doi: 10.1371/journal.pone.0022949. Epub 2011 Sep 1.

19.

Fluorinated cannabinoid CB2 receptor ligands: synthesis and in vitro binding characteristics of 2-oxoquinoline derivatives.

Turkman N, Shavrin A, Ivanov RA, Rabinovich B, Volgin A, Gelovani JG, Alauddin MM.

Bioorg Med Chem. 2011 Sep 15;19(18):5698-707. doi: 10.1016/j.bmc.2011.07.062. Epub 2011 Aug 5.

20.

HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistance.

Schwartz DL, Bankson J, Bidaut L, He Y, Williams R, Lemos R, Thitai AK, Oh J, Volgin A, Soghomonyan S, Yeh HH, Nishii R, Mukhopadhay U, Alauddin M, Mushkudiani I, Kuno N, Krishnan S, Bornman W, Lai SY, Powis G, Hazle J, Gelovani J.

Mol Cancer Res. 2011 Mar;9(3):259-70. doi: 10.1158/1541-7786.MCR-10-0469. Epub 2011 Mar 1.

21.

Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT.

Yeh HH, Ogawa K, Balatoni J, Mukhapadhyay U, Pal A, Gonzalez-Lepera C, Shavrin A, Soghomonyan S, Flores L 2nd, Young D, Volgin AY, Najjar AM, Krasnykh V, Tong W, Alauddin MM, Gelovani JG.

Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1603-8. doi: 10.1073/pnas.1010744108. Epub 2011 Jan 10.

22.

Radiosynthesis and initial in vitro evaluation of [18F]F-PEG6-IPQA--a novel PET radiotracer for imaging EGFR expression-activity in lung carcinomas.

Pal A, Balatoni JA, Mukhopadhyay U, Ogawa K, Gonzalez-Lepera C, Shavrin A, Volgin A, Tong W, Alauddin MM, Gelovani JG.

Mol Imaging Biol. 2011 Oct;13(5):853-61. doi: 10.1007/s11307-010-0408-8.

23.

Synthesis and ex vivo autoradiographic evaluation of ethyl-β-D-galactopyranosyl-(1,4')-2'-deoxy-2'-[18F]fluoro-β-D-glucopyranoside--a novel radioligand for lactose-binding protein: implications for early detection of pancreatic carcinomas with PET.

Ying Y, Ghosh P, Guo L, Pal A, Mukhapadhyay U, Peng Z, Yeh HH, Bertolini S, Flores LG, Young D, Volgin A, Soghomonyan S, Bornmann W, Logsdon C, Alauddin MM, Gelovani JG.

Mol Imaging Biol. 2011 Jun;13(3):536-546. doi: 10.1007/s11307-010-0334-9.

PMID:
20593279
24.

Detection of pancreatic carcinomas by imaging lactose-binding protein expression in peritumoral pancreas using [18F]fluoroethyl-deoxylactose PET/CT.

Flores LG, Bertolini S, Yeh HH, Young D, Mukhopadhyay U, Pal A, Ying Y, Volgin A, Shavrin A, Soghomonyan S, Tong W, Bornmann W, Alauddin MM, Logsdon C, Gelovani JG.

PLoS One. 2009 Nov 24;4(11):e7977. doi: 10.1371/journal.pone.0007977.

25.

The selective hypoxia inducible factor-1 inhibitor PX-478 provides in vivo radiosensitization through tumor stromal effects.

Schwartz DL, Powis G, Thitai-Kumar A, He Y, Bankson J, Williams R, Lemos R, Oh J, Volgin A, Soghomonyan S, Nishii R, Alauddin M, Mukhopadhay U, Peng Z, Bornmann W, Gelovani J.

Mol Cancer Ther. 2009 Apr;8(4):947-58. doi: 10.1158/1535-7163.MCT-08-0981.

26.

Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells.

Zinner RG, Barrett BL, Popova E, Damien P, Volgin AY, Gelovani JG, Lotan R, Tran HT, Pisano C, Mills GB, Mao L, Hong WK, Lippman SM, Miller JH.

Mol Cancer Ther. 2009 Mar;8(3):521-32. doi: 10.1158/1535-7163.MCT-08-0937. Epub 2009 Mar 10.

27.

Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs.

Najjar AM, Nishii R, Maxwell DS, Volgin A, Mukhopadhyay U, Bornmann WG, Tong W, Alauddin M, Gelovani JG.

J Nucl Med. 2009 Mar;50(3):409-16. doi: 10.2967/jnumed.108.058735. Epub 2009 Feb 17.

28.

Optimizing imaging of three-dimensional multicellular tumor spheroids with fluorescent reporter proteins using confocal microscopy.

le Roux L, Volgin A, Maxwell D, Ishihara K, Gelovani J, Schellingerhout D.

Mol Imaging. 2008 Sep-Oct;7(5):214-21.

PMID:
19123991
29.

N(3)-Substituted thymidine analogues V: synthesis and preliminary PET imaging of N(3)-[(18)F]fluoroethyl thymidine and N(3)-[(18)F]fluoropropyl thymidine.

Mukhopadhyay U, Soghomonyan S, Yeh HH, Flores LG, Shavrin A, Volgin AY, Gelovani JG, Alauddin MM.

Nucl Med Biol. 2008 Aug;35(6):697-705. doi: 10.1016/j.nucmedbio.2008.03.007.

PMID:
18678355
30.

Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model.

Park SI, Zhang J, Phillips KA, Araujo JC, Najjar AM, Volgin AY, Gelovani JG, Kim SJ, Wang Z, Gallick GE.

Cancer Res. 2008 May 1;68(9):3323-33. doi: 10.1158/0008-5472.CAN-07-2997.

31.

[Main center of sanitary and epidemiological control of Ministry of Defense of Russian Federation--35 years].

Volgin AR, Zhokin VF, Bosachenko IuV, Liashenko NI.

Voen Med Zh. 2007 Nov;328(11):64-8. Russian. No abstract available.

PMID:
18306714
32.

Evaluation of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-beta-L: -arabinofuranosyluracil ([18F]-L: -FMAU) as a PET imaging agent for cellular proliferation: comparison with [18F]-D: -FMAU and [18F]FLT.

Nishii R, Volgin AY, Mawlawi O, Mukhopadhyay U, Pal A, Bornmann W, Gelovani JG, Alauddin MM.

Eur J Nucl Med Mol Imaging. 2008 May;35(5):990-8. Epub 2007 Dec 4.

PMID:
18057932
33.

[The modern aspects of vernal encephalitis problems: the epidemic process, diagnosis and prophylaxis].

Volgin AR, Lukin EP, Liashenko NI.

Voen Med Zh. 2007 May;328(5):48-57. Russian. No abstract available.

PMID:
17726965
34.
36.

Optimizing heat shock protein expression induced by prostate cancer laser therapy through predictive computational models.

Rylander MN, Feng Y, Zhang Y, Bass J, Jason Stafford R, Volgin A, Hazle JD, Diller KR.

J Biomed Opt. 2006 Jul-Aug;11(4):041113.

PMID:
16965141
37.

[The experience of preventing infectious diseases during liquidation of tsunami consequence in Indonesia].

Mel'nichenko PI, Lobzin IuV, Korniushko IG, Volzhanin VM, Ogarkov PI, Vasil'ev VV, Kovalenko AN, Solov'ev AI, Volgin AR.

Voen Med Zh. 2005 Jun;326(6):4-8. Review. Russian. No abstract available.

PMID:
16053040
38.

[Experience of using bacterial lysate IRS 19 for the prophylaxis of the diseases of respiratory organs in organized groups].

Volgin AR, Demina IuV.

Zh Mikrobiol Epidemiol Immunobiol. 2005 May-Jun;(3):82-4. Russian.

PMID:
16028523
39.

[Current approaches to the registering and prevention of hospital infections].

Volgin AR, Zhokin VF.

Voen Med Zh. 1999 Mar;320(3):52-5, 96. Russian.

PMID:
10319712
40.

[Comparative characteristics of some parameters of the cell nucleus in the series myeloma-hybridoma-lymphocyte].

Sokolova IA, Volgin AIu, Smirnova TD, Lupga IP, Khodarev NN, Shishkin SS.

Biokhimiia. 1993 Mar;58(3):357-66. Russian.

PMID:
8485224
41.

Internucleosomal chromatin degradation in myeloma and B-hybridoma cell cultures.

Sokolova IA, Volgin AU, Makarova NV, Volgina VV, Shishkin SS, Khodarev NN.

FEBS Lett. 1992 Nov 30;313(3):295-9.

42.

[Use of monoclonal antibodies against myosin light chain 1 for detecting corresponding antigens in the blood of patients with myocardial infarct].

Puliaeva EV, Konorova AL, Kovalev LI, Volgin AIu, Shishkin SS, Pevnitskiĭ LA.

Biull Eksp Biol Med. 1991 Oct;112(10):416-7. Russian. No abstract available.

PMID:
1804360
43.

[Identification of myosin light chain 1 from human heart ventricles on two-dimensional electrophoretograms using monoclonal antibodies].

Kovalev LI, Volgin AIu, Konorova AL, Tsvetkova MN, Puliaeva EV, Pevnitskiĭ LA, Shishkin SS.

Biokhimiia. 1990 Oct;55(10):1911-3. Russian.

PMID:
2078631
44.

[Use of monoclonal antibodies in comparative studies of Ca, Mg-dependent endonuclease in cell nuclei].

Volgina VV, Khodarev NN, Volgin AIu, Votrin II, Pevnitskiĭ LA.

Biull Eksp Biol Med. 1988 Apr;105(4):419-21. Russian.

PMID:
2451945
45.

[Production of antibodies by hybridomas in a serum-free culture medium].

Pinchuk GV, Volgin AIu, Chernikov VG.

Eksp Onkol. 1984;6(5):74-5. Russian.

PMID:
6510350
46.

[Changes in the detectability of HLA antigens on lymphocyte subpopulations induced by mitogens and corticosteroids].

Volgin AIu, Pevnitskiĭ LA.

Biull Eksp Biol Med. 1982 Jan;93(1):45-7. Russian.

PMID:
6978158
47.

[Changes in the expression of HLA-antigens on lymphocytes after certain types of treatment].

Volgin AIu.

Biull Eksp Biol Med. 1981 Aug;92(8):68-71. Russian.

PMID:
7295967
48.

[Supressor activity of spleen cells during medically induced immunologic tolerance].

Pisarev VM, Volgin AIu.

Biull Eksp Biol Med. 1978 Nov;86(11):558-60. Russian.

PMID:
309777

Supplemental Content

Loading ...
Support Center